A complete solution for rapid diagnostics of coronavirus infection

With its two complementary platform technologies Amplidiag® and Novodiag®, Mobidiag has the capacity to meet the needs of clinical laboratories and multiple healthcare settings. Currently on the market, these platforms combine high quality and affordable costs, allowing widespread use both in mass screening and on-demand highly targeted or syndromic tests for various infectious diseases. The extremely versatile product offer, the flexibility of the technologies used, and the expertise of the Mobidiag team allow great responsiveness in the development of new products in emergency situations. Solutions offered by Mobidiag in the case of the coronavirus pandemic is a perfect example.

The first available test is the Anti-SARS-CoV-2 Rapid Test. This immunoassay allows detection of IgG and IgM from human serum, whole blood or plasma in about 15 minutes. Manufactured by Autobio Diagnostics, Mobidiag key partner and leading clinical diagnostics company in the Chinese the market, the Anti-SARS-CoV-2 test is now available through Mobidiag sales channels as well as our local distributors (except in Portugal, the Netherlands and Ukraine).

Currently, 2 complementary molecular tests are being developed by Mobidiag: Novodiag® COVID-19 and Amplidiag® COVID-19 , making it one the most complete solution for rapid diagnostics of coronavirus infection on the market.

Please note that Mobidiag tests are not home testing kits. They are only available for healthcare professionals, and not for patients directly. Based on your location, follow the recommended process if you believe you could be infected by SARS-CoV-2.

Choose the right coronavirus test based on your needs

Anti-SARS-CoV-2 Rapid Test* Novodiag® COVID-19 Amplidiag® COVID-19
Product no. RTA0202 / RTA0203 NVD-CV-012 AD-CV-864
Package size 20 cassettes / 50 cassettes 12 cartridges 9x96 tests
Sample type Human serum, plasma or whole blood Nasopharyngeal swab Nasopharyngeal swab
Technology Lateral flow PCR PCR
Targets SARS-CoV-2 antibodies (IgM and IgG) SARS-CoV-2 (orf1ab)
SARS-CoV-2 (N)
SARS-CoV-2 (orf1ab)
SARS-CoV-2 (N)
Time to results < 15min About 1h < 3h
Benefits Fast
Easy to use
Can detect acute and late infections from previous infections
Fast
Easy to use
Fully automated
Low hands-on time (<5min)
Detection at early infection stage
Closed system ensuring safety of healthcare professionals
Large volumes
Automated process fro DNA extraction and PCR set up
Detection at early infection stage
Availability CE-IVD Under development Under development

*Manufactured by Autobio Diagnostics, Mobidiag key partner and market leading Chinese clinical diagnostics company

Key Advantages

- A complete solution for rapid diagnostics of coronavirus infection
- A test for all sample volumes
- Discriminate between acute, late or past infections

Dedicated tests

Complete solution for rapid diagnostics of coronavirus infection

Anti-SARS-CoV-2 Rapid Test

CE-IVD. For in vitro diagnostic use.

The immunoassay Anti-SARS-CoV-2 Rapid Test (manufactured by Autobio Diagnostics) is based on a colloidal gold method for the rapid, qualitative determination of Anti-SARS-CoV-2 (IgG/IgM antibodies of Severe Acute Respiratory Syndrome Coronavirus 2) in human serum, plasma or whole blood.
This assay is based upon one-step capture method. It contains a membrane, which is pre-coated with two mouse anti-human monoclonal antibodies (anti-IgG and anti-IgM) on two separated test lines.

Please note that Mobidiag tests are not home testing kits. They are only available for healthcare professionals, and not for patients directly. Based on your location, follow the recommended process if you believe you could be infected by SARS-CoV-2.

Contact sales@mobidiag.com or fill in the form below for more information and orders.

A complete solution for rapid diagnostics of coronavirus infection
Novodiag COVID-19

Novodiag® COVID-19 (under dev.)

Under development.

The upcoming Novodiag® COVID-19 test will operate using the rapid ‘sample-in, result-out’ Novodiag® system, allowing the rapid detection of novel coronavirus in less than 1 hour.
This fully automated solution protects laboratory staff from potential contamination. With its user-friendly nature, the Novodiag® COVID-19 solution can be delivered to and will be targeted for use in high risk and hard to reach areas without the need for highly trained personnel.
This qualitative real-time PCR test will support decisions to manage efficiently epidemiological and infection control measures, isolate patients in a timely manner and improve patient care globally.

Please note that Mobidiag tests are not home testing kits. They are only available for healthcare professionals, and not for patients directly. Based on your location, follow the recommended process if you believe you could be infected by SARS-CoV-2.

Contact sales@mobidiag.com or fill in the form below for more information and orders.

A complete solution for rapid diagnostics of coronavirus infection

Amplidiag® COVID-19 (under dev.)

Under development.

The upcoming Amplidiag® COVID-19 test allows the rapid detection of novel coronavirus. By allowing rapid and reliable detection of this novel coronavirus, this qualitative real-time PCR test supports decisions to manage efficiently epidemiological and infection control measures, isolate patients in a timely manner and improve patient care globally.

Please note that Mobidiag tests are not home testing kits. They are only available for healthcare professionals, and not for patients directly. Based on your location, follow the recommended process if you believe you could be infected by SARS-CoV-2.

Contact sales@mobidiag.com or fill in the form below for more information and orders.